|

Docirbrutinib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AS-1763

Pipeline

Phase 1: 1

Top Sponsors

  • Carna Biosciences, Inc.1

Indications

  • Waldenstrom Macroglobulinemia1
  • B-cell Malignancy1
  • Small Lymphocytic Lymphoma1
  • Chronic Lymphocytic Leukemia1
  • Non-hodgkin Lymphoma1

Orange, California1 trial

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

UC Irvine Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.